Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa, Genzyme CorpfiledCriticalSanofi Sa
Publication of AR118756A1publicationCriticalpatent/AR118756A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Abstract
Se proporcionan en este documento anticuerpos que se unen específicamente a CD38 humano, formulaciones y formas de dosificación unitaria que comprenden los anticuerpos, métodos de preparación de los anticuerpos y métodos de uso de los anticuerpos.Provided herein are antibodies that specifically bind human CD38, formulations and unit dosage forms comprising the antibodies, methods of preparing the antibodies, and methods of using the antibodies.
ARP200101138A2019-04-232020-04-23
ANTIBODIES AND ANTI-CD38 FORMULATIONS
AR118756A1
(en)